NO20020062L - Behandling av nevrotiske forstyrrelser - Google Patents

Behandling av nevrotiske forstyrrelser

Info

Publication number: NO20020062L
Authority: NO; Norway
Prior art keywords: treatment; neurotic disorders; neurotic; disorders
Prior art date: 1999-07-08

Application number

NO20020062A

Other languages

English (en)

Other versions

NO20020062D0 (no

NO329021B1 (no

Inventor

Connie Sanchez

Sandra Hogg

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-07-08

Filing date

2002-01-07

Publication date

2002-01-07

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8099796&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20020062(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-01-07 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

2002-01-07 Publication of NO20020062D0 publication Critical patent/NO20020062D0/no

2002-01-07 Publication of NO20020062L publication Critical patent/NO20020062L/no

2010-07-26 Publication of NO329021B1 publication Critical patent/NO329021B1/no

Links

206010029333 Neurosis Diseases 0.000 title 1
208000015238 neurotic disease Diseases 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Anesthesiology (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Plural Heterocyclic Compounds (AREA)
Compounds Of Unknown Constitution (AREA)

NO20020062A 1999-07-08 2002-01-07 Anvendelse av escitalopram for behandling av generell angstforstyrrelse NO329021B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA199900991		1999-07-08
PCT/DK2000/000377 WO2001003694A1 (en)	1999-07-08	2000-07-07	Treatment of neurotic disorders

Publications (3)

Publication Number	Publication Date
NO20020062D0 NO20020062D0 (no)	2002-01-07
NO20020062L true NO20020062L (no)	2002-01-07
NO329021B1 NO329021B1 (no)	2010-07-26

Family

ID=8099796

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
NO20020062A NO329021B1 (no)	1999-07-08	2002-01-07	Anvendelse av escitalopram for behandling av generell angstforstyrrelse
NO20100334A NO20100334L (no)	1999-07-08	2010-03-10	Behandling av nevrotiske forstyrrelser
NO20100333A NO20100333L (no)	1999-07-08	2010-03-10	Behandling av nevrotiske forstyrrelser
NO20100335A NO20100335L (no)	1999-07-08	2010-03-10	Behandling av nevrotiske forstyrrelser

Family Applications After (3)

Application Number	Title	Priority Date	Filing Date
NO20100334A NO20100334L (no)	1999-07-08	2010-03-10	Behandling av nevrotiske forstyrrelser
NO20100333A NO20100333L (no)	1999-07-08	2010-03-10	Behandling av nevrotiske forstyrrelser
NO20100335A NO20100335L (no)	1999-07-08	2010-03-10	Behandling av nevrotiske forstyrrelser

Country Status (38)

Country	Link
US (6)	US7271194B2 (no)
EP (4)	EP1440691A3 (no)
JP (1)	JP4773011B2 (no)
KR (1)	KR100604176B1 (no)
CN (1)	CN1198610C (no)
AR (1)	AR021155A1 (no)
AT (1)	ATE339955T1 (no)
AU (6)	AU782514B2 (no)
BG (4)	BG106279A (no)
BR (1)	BR0011578A (no)
CA (4)	CA2687394A1 (no)
CL (3)	CL2008003938A1 (no)
CO (1)	CO5190674A1 (no)
CY (1)	CY1105806T1 (no)
CZ (1)	CZ200270A3 (no)
DE (1)	DE60030861T2 (no)
DK (1)	DK1200081T3 (no)
EA (1)	EA006555B1 (no)
ES (1)	ES2272298T3 (no)
HK (1)	HK1048069B (no)
HR (1)	HRP20010820A2 (no)
HU (1)	HUP0201791A3 (no)
IL (5)	IL146131A0 (no)
IS (1)	IS6137A (no)
ME (2)	ME00032B (no)
MX (1)	MXPA01011626A (no)
MY (1)	MY143278A (no)
NO (4)	NO329021B1 (no)
PL (1)	PL352030A1 (no)
PT (1)	PT1200081E (no)
SI (1)	SI1200081T1 (no)
SK (1)	SK82002A3 (no)
TR (4)	TR200402276T2 (no)
TW (1)	TWI232101B (no)
UA (1)	UA77645C2 (no)
WO (1)	WO2001003694A1 (no)
YU (1)	YU78701A (no)
ZA (1)	ZA200108856B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR021155A1 (es)	1999-07-08	2002-06-12	Lundbeck & Co As H	Tratamiento de desordenes neuroticos
GB0005477D0 (en)	2000-03-07	2000-04-26	Resolution Chemicals Limited	Process for the preparation of citalopram
AU8174001A (en)	2000-07-21	2002-02-05	Lundbeck & Co As H	Novel compounds and their use as glycine transport inhibitors
WO2002087566A1 (en) *	2001-05-01	2002-11-07	H. Lundbeck A/S	The use of enantiomeric pure escitalopram
IL159326A0 (en)	2001-07-31	2004-06-01	Lundbeck & Co As H	Crystalline composition containing escitalopram
AU2003237524A1 (en) *	2002-07-08	2004-01-23	University Of Florida	Use of ssri inhibitors to prevent or ameliorate trauma-related psychological disorders
US20050137255A1 (en) *	2002-12-23	2005-06-23	H. Lundbeck A/S	Crystalline escitalopram hydrobromide and methods for preparing the same
AU2003287919B2 (en) *	2002-12-23	2009-11-12	H. Lundbeck A/S	Escitalopram hydrobromide and a method for the preparation thereof
WO2004085416A1 (en) *	2003-03-24	2004-10-07	Hetero Drugs Limited	Novel crystalline forms of (s)-citalopram oxalate
US20090093461A1 (en) *	2003-07-02	2009-04-09	Astrazeneca Ab	Methods of Treating Anxiety and Mood Disorders
US7884096B2 (en) *	2003-12-02	2011-02-08	Pharmaneuroboost N.V.	Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
EP1708790B1 (en) *	2003-12-02	2010-04-21	PharmaNeuroBoost N.V.	Use of pipamperone and a d2-receptor antagonist or a serotonin/dopamin antagonist for the treatment of psychotic disorders
US7855195B2 (en) *	2003-12-02	2010-12-21	Pharmaneuroboost N.V.	Method of treating mental disorders using D4 and 5-HT2A antagonists, inverse agonists or partial agonists
EA200801081A1 (ru)	2005-10-14	2008-10-30	Х. Лундбекк А/С	Способы лечения расстройств центральной нервной системы комбинацией малых доз эсциталопрама и бупропиона
US20070134322A1 (en) *	2005-12-14	2007-06-14	Forest Laboratories, Inc.	Modified and pulsatile release pharmaceutical formulations of escitalopram
FR2912057B1 (fr) *	2007-02-07	2009-04-17	Sanofi Aventis Sa	Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
TW200817003A (en) *	2006-07-31	2008-04-16	Sanofi Aventis	Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1143703A (no) *	1965-03-18
GB1526331A (en) *	1976-01-14	1978-09-27	Kefalas As	Phthalanes
US4436874A (en)	1981-11-19	1984-03-13	Societe D'expansion Scientifique "Expansia"	Acrylic copolymers and their use in solid phase peptide synthesis
GB8419963D0 (en) *	1984-08-06	1984-09-12	Lundbeck & Co As H	Intermediate compound and method
GB8607313D0 (en) *	1986-03-25	1986-04-30	Ici Plc	Pharmaceutical compositions
GB8814057D0 (en) *	1988-06-14	1988-07-20	Lundbeck & Co As H	New enantiomers & their isolation
US4902710A (en) *	1988-12-14	1990-02-20	Eli Lilly And Company	Serotonin and norepinephrine uptake inhibitors
US5114976A (en) *	1989-01-06	1992-05-19	Norden Michael J	Method for treating certain psychiatric disorders and certain psychiatric symptoms
US4962128A (en) *	1989-11-02	1990-10-09	Pfizer Inc.	Method of treating anxiety-related disorders using sertraline
US5296507A (en) *	1990-09-06	1994-03-22	H.Lundbeck A/S	Treatment of cerbrovascular disorders
DK213290D0 (da)	1990-09-06	1990-09-06	Lundbeck & Co As H	Treatment of cerebrovascular disorders
US5708035A (en) *	1991-02-04	1998-01-13	Sepracor Inc.	Methods of use and compositions of R(-) fluoxetine
WO1992018005A1 (en)	1991-04-16	1992-10-29	National Institutes Of Health	Method of treating trichotillomania and onychophagia
ATE244563T1 (de)	1991-11-15	2003-07-15	Sepracor Inc	Verwendung von reinem fluoxetin-s(+)-isomer für die herstellung eines medikements gegen migräne
EP0714663A3 (en) *	1994-11-28	1997-01-15	Lilly Co Eli	Potentiation of drug responses by serotonin 1A receptor antagonists
US5627196A (en) *	1995-01-17	1997-05-06	Eli Lilly And Company	Compounds having effects on serotonin-related systems
AU4918796A (en) *	1995-02-10	1996-08-27	Eli Lilly And Company	Methods of treating or preventing psychiatric disorders
US5554383A (en) *	1995-04-06	1996-09-10	Trustees Of Tufts College	Veterinary method for clinically modifying the behavior of dogs exhibiting canine affective aggression
SE9501567D0 (sv) *	1995-04-27	1995-04-27	Astra Ab	A new combination
DK0759299T3 (da)	1995-08-16	2000-08-07	Lilly Co Eli	Potensering af serotoninrespons
US5846982A (en) *	1996-06-14	1998-12-08	Eli Lilly And Company	Inhibition of serotonin reuptake
US5912256A (en) *	1996-06-20	1999-06-15	Eli Lilly And Company	Compounds having effects on serotonin-related systems
US5747494A (en) *	1996-06-28	1998-05-05	U C B S.A.	Pharmaceutical compositions for the treatment of depressive disorders
US5958429A (en) *	1996-08-16	1999-09-28	Eli Lilly And Company	Potentiation of serotonin response
ZA977967B (en) *	1996-09-23	1999-03-04	Lilly Co Eli	Combination therapy for treatment of psychoses
US5776969A (en) *	1997-02-27	1998-07-07	Eli Lilly And Company	Treatment of sleep disorders
US6069177A (en) *	1997-07-08	2000-05-30	The Hong Kong University Of Science And Technology	3-Hydroxy-propanamine derived neuronal reuptake inhibitors
SE9703379D0 (sv) *	1997-09-18	1997-09-18	Astra Ab	New compounds
SE9703375D0 (sv) *	1997-09-18	1997-09-18	Astra Ab	A new combination
EA002770B1 (ru) *	1997-11-11	2002-08-29	Х.Лундбекк А/С	Способ получения циталопрама
DE69903992T2 (de) *	1998-04-15	2003-08-21	Pfizer Products Inc., Groton	Heterocyclische Carboxamide
AU4850199A (en) *	1998-06-30	2000-01-17	Eli Lilly And Company	Pyrrolidine and pyrroline derivatives having effects on serotonin related systems
WO2000002551A2 (en)	1998-07-13	2000-01-20	Nps Pharmaceuticals, Inc.	Methods and compounds for treating depression
CA2337507A1 (en)	1998-07-16	2000-01-27	Massachusetts Institute Of Technology	Composition for treatment of stress
US6579899B1 (en)	1998-07-16	2003-06-17	Massachusetts Institute Of Technology	Composition for treatment of stress
US6150376A (en) *	1998-08-05	2000-11-21	Georgetown University	Bi- and tri-cyclic aza compounds and their uses
SE9803157D0 (sv)	1998-09-16	1998-09-16	Astra Ab	A new composition
SE9803158D0 (sv) *	1998-09-16	1998-09-16	Astra Ab	A new composition
PL199423B1 (pl) *	1998-10-20	2008-09-30	Lundbeck & Co As H	Sposób wytwarzania citalopramu
AR021509A1 (es) *	1998-12-08	2002-07-24	Lundbeck & Co As H	Derivados de benzofurano, su preparacion y uso
DK1173431T4 (da) *	1999-04-14	2010-01-04	Lundbeck & Co As H	Fremgangsmåde til fremstilling af citalopram
AR021155A1 (es)	1999-07-08	2002-06-12	Lundbeck & Co As H	Tratamiento de desordenes neuroticos
US6333357B1 (en) *	1999-11-05	2001-12-25	Be Able, Llc	Behavior chemotherapy
UA77650C2 (en) *	1999-12-06	2007-01-15	Lundbeck & Co As H	Use of serotonin reuptake inhibitor in combination with deramcyclane
GB2357762B (en) *	2000-03-13	2002-01-30	Lundbeck & Co As H	Crystalline base of citalopram
US6469064B2 (en) *	2000-04-24	2002-10-22	Aryx Therapeutics	Materials and methods for the treatment of depression
JP2002361405A (ja) *	2000-09-25	2002-12-18	Showa Denko Kk	熱交換器の製造方法
WO2002087566A1 (en) *	2001-05-01	2002-11-07	H. Lundbeck A/S	The use of enantiomeric pure escitalopram

2000
- 2000-07-06 AR ARP000103442A patent/AR021155A1/es unknown
- 2000-07-07 MX MXPA01011626A patent/MXPA01011626A/es not_active Application Discontinuation
- 2000-07-07 HR HR20010820A patent/HRP20010820A2/hr not_active Application Discontinuation
- 2000-07-07 SI SI200030910T patent/SI1200081T1/sl unknown
- 2000-07-07 DK DK00943692T patent/DK1200081T3/da active
- 2000-07-07 CN CNB008100292A patent/CN1198610C/zh not_active Expired - Lifetime
- 2000-07-07 EP EP04007522A patent/EP1440691A3/en not_active Withdrawn
- 2000-07-07 MY MYPI20003122A patent/MY143278A/en unknown
- 2000-07-07 EA EA200200137A patent/EA006555B1/ru not_active IP Right Cessation
- 2000-07-07 PL PL00352030A patent/PL352030A1/xx not_active Application Discontinuation
- 2000-07-07 IL IL14613100A patent/IL146131A0/xx unknown
- 2000-07-07 DE DE60030861T patent/DE60030861T2/de not_active Expired - Lifetime
- 2000-07-07 TR TR2004/02276T patent/TR200402276T2/xx unknown
- 2000-07-07 UA UA2001128286A patent/UA77645C2/uk unknown
- 2000-07-07 ME MEP-2008-25A patent/ME00032B/me unknown
- 2000-07-07 CA CA2687394A patent/CA2687394A1/en not_active Abandoned
- 2000-07-07 CZ CZ200270A patent/CZ200270A3/cs unknown
- 2000-07-07 HK HK03100231.6A patent/HK1048069B/zh not_active IP Right Cessation
- 2000-07-07 TR TR2004/02275T patent/TR200402275T2/xx unknown
- 2000-07-07 WO PCT/DK2000/000377 patent/WO2001003694A1/en not_active Ceased
- 2000-07-07 CA CA2687396A patent/CA2687396A1/en not_active Abandoned
- 2000-07-07 AU AU58061/00A patent/AU782514B2/en not_active Expired
- 2000-07-07 TR TR2004/02277T patent/TR200402277T2/xx unknown
- 2000-07-07 KR KR1020017016006A patent/KR100604176B1/ko not_active Ceased
- 2000-07-07 YU YU78701A patent/YU78701A/sh unknown
- 2000-07-07 JP JP2001508974A patent/JP4773011B2/ja not_active Expired - Lifetime
- 2000-07-07 CA CA2687392A patent/CA2687392A1/en not_active Abandoned
- 2000-07-07 SK SK8-2002A patent/SK82002A3/sk not_active Application Discontinuation
- 2000-07-07 HU HU0201791A patent/HUP0201791A3/hu unknown
- 2000-07-07 BR BR0011578-9A patent/BR0011578A/pt active Search and Examination
- 2000-07-07 EP EP04007521A patent/EP1440690A3/en not_active Withdrawn
- 2000-07-07 AT AT00943692T patent/ATE339955T1/de active
- 2000-07-07 CO CO00051031A patent/CO5190674A1/es not_active Application Discontinuation
- 2000-07-07 ES ES00943692T patent/ES2272298T3/es not_active Expired - Lifetime
- 2000-07-07 CA CA002373757A patent/CA2373757C/en not_active Expired - Lifetime
- 2000-07-07 EP EP04007520A patent/EP1440689A3/en not_active Withdrawn
- 2000-07-07 PT PT00943692T patent/PT1200081E/pt unknown
- 2000-07-07 ME MEP-25/08A patent/MEP2508A/xx unknown
- 2000-07-07 TR TR2002/00014T patent/TR200200014T2/xx unknown
- 2000-07-07 EP EP00943692A patent/EP1200081B1/en not_active Revoked
- 2000-07-28 TW TW089115110A patent/TWI232101B/zh not_active IP Right Cessation
2001
- 2001-10-23 IL IL146131A patent/IL146131A/en active IP Right Grant
- 2001-10-26 ZA ZA200108856A patent/ZA200108856B/xx unknown
- 2001-10-30 IS IS6137A patent/IS6137A/is unknown
- 2001-12-12 US US10/021,126 patent/US7271194B2/en not_active Expired - Lifetime
2002
- 2002-01-04 BG BG106279A patent/BG106279A/bg unknown
- 2002-01-04 BG BG11046709A patent/BG110467A/bg unknown
- 2002-01-04 BG BG11046609A patent/BG110466A/bg unknown
- 2002-01-04 BG BG11046809A patent/BG110468A/bg unknown
- 2002-01-07 NO NO20020062A patent/NO329021B1/no not_active IP Right Cessation
2003
- 2003-08-07 US US10/637,821 patent/US20040029957A1/en not_active Abandoned
- 2003-08-07 US US10/637,820 patent/US7265151B2/en not_active Expired - Lifetime
- 2003-08-07 US US10/637,822 patent/US20040029958A1/en not_active Abandoned
- 2003-08-20 US US10/644,143 patent/US6960613B2/en not_active Expired - Lifetime
2005
- 2005-06-20 AU AU2005202686A patent/AU2005202686B2/en not_active Expired
- 2005-06-20 AU AU2005202685A patent/AU2005202685B2/en not_active Ceased
- 2005-06-20 AU AU2005202684A patent/AU2005202684B2/en not_active Ceased
- 2005-08-09 IL IL170192A patent/IL170192A/en unknown
- 2005-08-09 IL IL170194A patent/IL170194A/en unknown
- 2005-08-09 IL IL170193A patent/IL170193A/en unknown
2006
- 2006-11-27 CY CY20061101706T patent/CY1105806T1/el unknown
2007
- 2007-08-10 US US11/837,317 patent/US20070276035A1/en not_active Abandoned
2008
- 2008-12-24 AU AU2008264188A patent/AU2008264188A1/en not_active Withdrawn
- 2008-12-24 AU AU2008264182A patent/AU2008264182A1/en not_active Withdrawn
- 2008-12-30 CL CL2008003938A patent/CL2008003938A1/es unknown
- 2008-12-30 CL CL2008003939A patent/CL2008003939A1/es unknown
- 2008-12-30 CL CL2008003941A patent/CL2008003941A1/es unknown
2010
- 2010-03-10 NO NO20100334A patent/NO20100334L/no not_active Application Discontinuation
- 2010-03-10 NO NO20100333A patent/NO20100333L/no not_active Application Discontinuation
- 2010-03-10 NO NO20100335A patent/NO20100335L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
YU78701A (sh)	2004-03-12
HUP0201791A3 (en)	2005-02-28
TR200402276T2 (tr)	2005-01-24
EP1440689A2 (en)	2004-07-28
BG110468A (en)	2010-01-29
EP1440691A2 (en)	2004-07-28
US20070276035A1 (en)	2007-11-29
AU782514B2 (en)	2005-08-04
JP4773011B2 (ja)	2011-09-14
TR200200014T2 (tr)	2002-05-21
WO2001003694A1 (en)	2001-01-18
BR0011578A (pt)	2002-03-26
MY143278A (en)	2011-04-15
CA2687394A1 (en)	2001-01-18
CN1360501A (zh)	2002-07-24
DK1200081T3 (da)	2006-12-27
UA77645C2 (en)	2007-01-15
EP1440691A3 (en)	2004-08-25
SK82002A3 (en)	2002-07-02
NO20020062D0 (no)	2002-01-07
AU5806100A (en)	2001-01-30
DE60030861D1 (de)	2006-11-02
US20020086899A1 (en)	2002-07-04
AU2005202685B2 (en)	2009-01-15
AU2005202684B2 (en)	2009-01-15
BG106279A (bg)	2002-08-30
IL170194A (en)	2010-05-31
EA200200137A1 (ru)	2002-06-27
CO5190674A1 (es)	2002-08-29
IL146131A0 (en)	2002-07-25
TWI232101B (en)	2005-05-11
NO20100334L (no)	2002-01-07
CA2687396A1 (en)	2001-01-18
IL170193A (en)	2010-04-29
EP1200081B1 (en)	2006-09-20
CL2008003938A1 (es)	2009-05-22
CZ200270A3 (cs)	2002-04-17
PL352030A1 (en)	2003-07-28
PT1200081E (pt)	2007-01-31
CL2008003939A1 (es)	2009-06-05
EP1440690A2 (en)	2004-07-28
JP2003504332A (ja)	2003-02-04
HK1048069B (zh)	2005-12-16
DE60030861T2 (de)	2007-05-03
US7265151B2 (en)	2007-09-04
AU2005202686B2 (en)	2009-01-15
US7271194B2 (en)	2007-09-18
CA2373757A1 (en)	2001-01-18
AU2005202685A1 (en)	2005-07-14
KR20020015346A (ko)	2002-02-27
MEP2508A (xx)	2010-02-10
BG110467A (en)	2010-01-29
NO20100335L (no)	2002-01-07
MXPA01011626A (es)	2002-06-04
US20040029956A1 (en)	2004-02-12
IS6137A (is)	2001-10-30
AU2005202684A1 (en)	2005-07-14
IL146131A (en)	2007-02-11
SI1200081T1 (sl)	2007-02-28
CN1198610C (zh)	2005-04-27
HUP0201791A2 (en)	2002-10-28
ZA200108856B (en)	2002-12-24
EA006555B1 (ru)	2006-02-24
CA2687392A1 (en)	2001-01-18
AU2008264188A1 (en)	2009-05-07
NO20100333L (no)	2002-01-07
US20050101665A1 (en)	2005-05-12
AU2008264182A1 (en)	2009-01-29
EP1440689A3 (en)	2004-08-25
TR200402275T2 (tr)	2005-03-21
NO329021B1 (no)	2010-07-26
US6960613B2 (en)	2005-11-01
HRP20010820A2 (en)	2003-08-31
US20040029957A1 (en)	2004-02-12
US20040029958A1 (en)	2004-02-12
CA2373757C (en)	2010-01-05
TR200402277T2 (tr)	2005-01-24
IL170192A (en)	2010-04-29
EP1440690A3 (en)	2004-08-18
EP1200081A1 (en)	2002-05-02
KR100604176B1 (ko)	2006-07-25
CY1105806T1 (el)	2011-02-02
ATE339955T1 (de)	2006-10-15
BG110466A (en)	2010-01-29
ME00032B (me)	2010-02-10
AU2005202686A1 (en)	2005-07-14
ES2272298T3 (es)	2007-05-01
HK1048069A1 (en)	2003-03-21
AR021155A1 (es)	2002-06-12
CL2008003941A1 (es)	2009-05-22

Legal Events

Date	Code	Title	Description
2008-07-14	CREP	Change of representative	Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104
2020-08-10	MK1K	Patent expired

Publication	Publication Date	Title
NO993051L (no)	1999-12-23	Intranasale formuleringer for behandling av seksuelle forstyrrelser
NO20026263L (no)	2002-12-27	Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser
NO20021845D0 (no)	2002-04-19	Behandling av sövnforstyrrelser under anvendelse av desloratadin
GB0007193D0 (en)	2000-05-17	Treatment of movrmrnt disorders
NO20020062D0 (no)	2002-01-07	Behandling av nevrotiske forstyrrelser
NO20052894D0 (no)	2005-06-14	4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
NO20005884D0 (no)	2000-11-21	Kombinasjonsterapi for behandling av bipolare forstyrrelser
NO20041386L (no)	2004-05-11	Kombinasjoner for bahandling av immunoinflammatoriske forstyrrelser
NO20024775D0 (no)	2002-10-03	Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20024486L (no)	2002-09-19	Forbedret behandling av neovaskularisering
EP1117431A4 (en)	2005-03-02	TREATMENT OF ACIDOSIS
ID27214A (id)	2001-03-08	Triazolopiridina untuk pengobatan gangguan trombosis
NO20024776D0 (no)	2002-10-03	Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte
NO20024777L (no)	2002-12-03	Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte
NO20024236L (no)	2002-09-05	Behandling av psoriasis
NO20032156D0 (no)	2003-05-13	Behandling av angstforstyrrelser
DE60026821D1 (de)	2006-05-11	Behandlung von bohrspülung
AR026062A1 (es)	2002-12-26	Tratamiento de desordenes oculares
NO20010390D0 (no)	2001-01-23	Behandling av angstsykdommer
NO20012612D0 (no)	2001-05-28	Isonipecotamider for behandling av integren-formidlede lidelser
NO20014477D0 (no)	2001-09-14	Behandling av osteoartritis
NO20030767L (no)	2003-02-18	Behandling av forbrenninger
IS6020A (is)	2001-07-23	S-nítrósóþíól til meðferðar við blóðrásartruflunum
DK82798A (da)	1998-05-28	Treatment of GABA-uptake related disorders
NO20042166L (no)	2004-05-25	Kombinasjonsterapi for behandling av sykdom